Primary and secondary outcomes between pre-ACS and post-ACS periods by hemodynamic status
| Outcomes | Stable | Tachycardia | Hypotension | ||||||
| Pre-ACS N=29 | Post-ACS N=87 | P value | Pre-ACS N=63 | Post-ACS N=89 | P value | Pre-ACS N=70 | Post-ACS N=83 | P value | |
| Mortality, n (%)* | 6 (21) | 19 (22) | >0.999 | 25 (40) | 18 (20) | 0.011 | 35 (50) | 25 (30) | 0.013 |
| LOS (days) (95% CI)† | 5.5 (3.4 to 7.5) | 5.5 (4.9 to 6.2) | 0.915 | 6.5 (5.3 to 7.6) | 5.4 (4.8 to 6.0) | 0.066 | 7.0 (5.6 to 8.5) | 5.9 (5.1 to 6.6) | 0.109 |
| Time to EGD (hours) (95% CI)† | 37 (21 to 53) | 24 (17 to 30) | 0.063 | 45 (33 to 57) | 27 (21 to 32) | 0.002 | 47 (29 to 64) | 26 (19 to 32) | 0.010 |
| %EGD, n (%)* | 23 (79) | 79 (91) | 0.111 | 45 (71) | 81 (91) | 0.002 | 45 (64) | 70 (84) | 0.005 |
| Complications (%)* | |||||||||
| Overall complications | 6 (21) | 19 (22) | >0.999 | 27 (43) | 24 (27) | 0.055 | 29 (41) | 27 (33) | 0.313 |
| Acute renal failure | 2 (7) | 17 (20) | 0.151 | 18 (29) | 15 (17) | 0.110 | 21 (30) | 21 (25) | 0.587 |
| Septicemia | 1 (3) | 4 (5) | >0.999 | 3 (5) | 5 (6) | >0.999 | 4 (6) | 4 (5) | >0.999 |
| Hepatic failure (complication) | 0 (0) | 4 (5) | 0.571 | 3 (5) | 0 (0) | 0.069 | 4 (6) | 2 (2) | 0.413 |
| Respiratory complications‡ | 5 (17) | 7 (8) | 0.171 | 19 (30) | 11 (12) | 0.012 | 14 (20) | 14 (17) | 0.677 |
| Pneumonia | 1 (3) | 0 (0) | 0.250 | 7 (11) | 2 (2) | 0.034 | 2 (3) | 3 (4) | >0.999 |
| Respiratory failure | 5 (17) | 7 (8) | 0.171 | 15 (24) | 11 (12) | 0.081 | 13 (19) | 12 (14) | 0.518 |
| Cardiovascular complications§ | 0 (0) | 2 (2) | >0.999 | 3 (5) | 0 (0) | 0.069 | 1 (1) | 3 (4) | 0.626 |
*Fisher’s exact test.
†Unpaired t-test.
‡Respiratory complications included pneumonia and respiratory failure.
§Cardiovascular complications included acute myocardial infarction, acute heart failure and acute heart conductive disorders.
ACS, acute care surgery; %EGD, proportion of patients undergoing esophagogastroduodenoscopy; EGD, esophagogastroduodenoscopy; LOS, length of hospital stay.